Get started
Author

Jérôme Drouin

Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people
2021 · Laura Semenzato, Jérémie Botton, et al. · The Lancet Regional Health - Europe · 257
The Economic Burden of Disease in France From the National Health Insurance Perspective
2022 · Antoine Rachas, Christelle Gastaldi-Ménager, et al. · Medical Care · 120
Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines
2022 · Stéphane Le Vu, Marion Bertrand, et al. · Nature Communications · 117
PDF
Antihypertensive Drugs and COVID-19 Risk
2021 · Laura Semenzato, Jérémie Botton, et al. · Hypertension · 117
Effectiveness and Safety of Reference Infliximab and Biosimilar in Crohn Disease: A French Equivalence Study
2018 · Antoine Meyer, Jérémie Rudant, et al. · Annals of Internal Medicine · 107
Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database
2016 · Philippe Tuppin, Sébastien Rivière, et al. · Archives of cardiovascular diseases · 90
PDF
Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France
2022 · Jérémie Botton, Marie Joelle Jabagi, et al. · Annals of Internal Medicine · 71
Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011–2016
2019 · Géric Maura, Cécile Billionnet, et al. · BMJ Open · 67
PDF
A modified self‐controlled case series method for event‐dependent exposures and high event‐related mortality, with application to COVID‐19 vaccine safety
2022 · Yonas Ghebremichael‐Weldeselassie, Marie Joëlle Jabagi, et al. · Statistics in Medicine · 62
PDF
Pregnancy in women with inflammatory bowel disease: a French nationwide study 2010‐2018
2020 · Antoine Meyer, Jérôme Drouin, et al. · Alimentary Pharmacology & Therapeutics · 62
Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies
2024 · Laura Semenzato, Stéphane Le Vu, et al. · JAMA · 55
PDF
Benefits and Risks Associated With Continuation of Anti–Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease
2022 · Antoine Meyer, Anke Neumann, et al. · Annals of Internal Medicine · 47
Serious Infections in Children Born to Mothers With Inflammatory Bowel Disease With In Utero Exposure to Thiopurines and Anti-Tumor Necrosis Factor
2021 · Antoine Meyer, Marion Taine, et al. · Clinical Gastroenterology and Hepatology · 45
Drug use for gastrointestinal symptoms during pregnancy: A French nationwide study 2010–2018
2021 · Antoine Meyer, Marion Fermaut, et al. · PLoS ONE · 37
PDF
The effectiveness and safety of infliximab compared with biosimilar CT‐P13, in 3112 patients with ulcerative colitis
2019 · Antoine Meyer, Jérémie Rudant, et al. · Alimentary Pharmacology & Therapeutics · 37
PDF
Prevalence, mortality, and treatment of patients with rheumatoid arthritis: A cohort study of the French National Health Data System, 2010–2019
2022 · Laura Pina Vegas, Jérôme Drouin, et al. · Joint Bone Spine · 36
Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in France
2022 · Laura Semenzato, Jérémie Botton, et al. · The Lancet Regional Health - Europe · 36
PDF
Comparative study of pregnancy outcomes in women with inflammatory bowel disease treated with thiopurines and/or anti‐TNF: a French nationwide study 2010–2018
2021 · Antoine Meyer, Jérôme Drouin, et al. · Alimentary Pharmacology & Therapeutics · 36
Safety of Vedolizumab and Ustekinumab Compared With Anti-TNF in Pregnant Women With Inflammatory Bowel Disease
2024 · Antoine Meyer, Sara Miranda, et al. · Clinical Gastroenterology and Hepatology · 35
Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study
2022 · Kim Bouillon, Bérangère Baricault, et al. · BMJ Medicine · 35
PDF
Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic
2020 · Sophie Billioti de Gage, Jérôme Drouin, et al. · JAMA Ophthalmology · 35
PDF
Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines
2023 · Stéphane Le Vu, Marion Bertrand, et al. · Neurology · 34
PDF
Mandatory Infant Vaccinations in France During the COVID-19 Pandemic in 2020
2021 · Marion Taine, Lucile Offredo, et al. · Frontiers in Pediatrics · 34
PDF
Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines
2021 · Jérémie Botton, Rosemary Dray-Spira, et al. · Vaccine · 29
Poids humain et économique des cancers en France en 2014, les données du Sniiram
2017 · Philippe Tuppin, Laurence Pestel, et al. · Bulletin du Cancer · 28
Works count: 79
Citation count: 2,031
H-index: 26
I10-index: 43
Year
Topic
Type